Literature DB >> 36087084

Five decades of progress in surgical oncology: Tumors of the lung and esophagus.

Valerie W Rusch1.   

Abstract

During the past 50 years, there has been a remarkable transformation in the management of lung and esophageal cancers. Improved methods of diagnosis, better staging and patient selection for surgery, the advent of minimally invasive approaches to resection, decreasing operative mortality, greater insights into tumor biology, and the development of effective multimodality therapies and precision medicine have contributed to this transformation. Progress has been most notable in lung cancer.
© 2022 Wiley Periodicals LLC.

Entities:  

Keywords:  esophageal cancer; lung cancer; treatment advances

Mesh:

Year:  2022        PMID: 36087084      PMCID: PMC9472872          DOI: 10.1002/jso.27033

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   2.885


  38 in total

1.  Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus.

Authors:  A Herskovic; K Martz; M al-Sarraf; L Leichman; J Brindle; V Vaitkevicius; J Cooper; R Byhardt; L Davis; B Emami
Journal:  N Engl J Med       Date:  1992-06-11       Impact factor: 91.245

2.  Reduced lung-cancer mortality with low-dose computed tomographic screening.

Authors:  Denise R Aberle; Amanda M Adams; Christine D Berg; William C Black; Jonathan D Clapp; Richard M Fagerstrom; Ilana F Gareen; Constantine Gatsonis; Pamela M Marcus; JoRean D Sicks
Journal:  N Engl J Med       Date:  2011-06-29       Impact factor: 91.245

3.  The utility of positron emission tomography in staging of potentially operable carcinoma of the thoracic esophagus: results of the American College of Surgeons Oncology Group Z0060 trial.

Authors:  Bryan F Meyers; Robert J Downey; Paul A Decker; Robert J Keenan; Barry A Siegel; Robert J Cerfolio; Rodney J Landreneau; Carolyn E Reed; Dennis M Balfe; Farrokh Dehdashti; Karla V Ballman; Valerie W Rusch; Joe B Putnam
Journal:  J Thorac Cardiovasc Surg       Date:  2007-03       Impact factor: 5.209

4.  Long-term Survival Based on the Surgical Approach to Lobectomy For Clinical Stage I Nonsmall Cell Lung Cancer: Comparison of Robotic, Video-assisted Thoracic Surgery, and Thoracotomy Lobectomy.

Authors:  Hao-Xian Yang; Kaitlin M Woo; Camelia S Sima; Manjit S Bains; Prasad S Adusumilli; James Huang; David J Finley; Nabil P Rizk; Valerie W Rusch; David R Jones; Bernard J Park
Journal:  Ann Surg       Date:  2017-02       Impact factor: 12.969

5.  Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160).

Authors:  Valerie W Rusch; Dorothy J Giroux; Michael J Kraut; John Crowley; Mark Hazuka; Timothy Winton; David H Johnson; Lawrence Shulman; Frances Shepherd; Claude Deschamps; Robert B Livingston; David Gandara
Journal:  J Clin Oncol       Date:  2007-01-20       Impact factor: 44.544

6.  Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC.

Authors:  Scott J Antonia; Augusto Villegas; Davey Daniel; David Vicente; Shuji Murakami; Rina Hui; Takayasu Kurata; Alberto Chiappori; Ki H Lee; Maike de Wit; Byoung C Cho; Maryam Bourhaba; Xavier Quantin; Takaaki Tokito; Tarek Mekhail; David Planchard; Young-Chul Kim; Christos S Karapetis; Sandrine Hiret; Gyula Ostoros; Kaoru Kubota; Jhanelle E Gray; Luis Paz-Ares; Javier de Castro Carpeño; Corinne Faivre-Finn; Martin Reck; Johan Vansteenkiste; David R Spigel; Catherine Wadsworth; Giovanni Melillo; Maria Taboada; Phillip A Dennis; Mustafa Özgüroğlu
Journal:  N Engl J Med       Date:  2018-09-25       Impact factor: 91.245

7.  New trends in skeletal reconstruction after resection of chest wall tumors.

Authors:  P McCormack; M S Bains; E J Beattie; N Martini
Journal:  Ann Thorac Surg       Date:  1981-01       Impact factor: 4.330

8.  Phase II trial of preoperative chemoradiotherapy followed by surgical resection in patients with superior sulcus non-small-cell lung cancers: report of Japan Clinical Oncology Group trial 9806.

Authors:  Hideo Kunitoh; Harubumi Kato; Masahiro Tsuboi; Taro Shibata; Hisao Asamura; Yukito Ichinose; Yukito Ichonose; Nobuyuki Katakami; Kanji Nagai; Tetsuya Mitsudomi; Akihide Matsumura; Ken Nakagawa; Hirohito Tada; Nagahiro Saijo
Journal:  J Clin Oncol       Date:  2008-02-01       Impact factor: 44.544

9.  The impact of complications on outcomes after resection for esophageal and gastroesophageal junction carcinoma.

Authors:  Nabil P Rizk; Peter B Bach; Deborah Schrag; Manjit S Bains; Alan D Turnbull; Martin Karpeh; Murray F Brennan; Valerie W Rusch
Journal:  J Am Coll Surg       Date:  2004-01       Impact factor: 6.113

10.  Two-Year Quality of Life Outcomes After Robotic-Assisted Minimally Invasive and Open Esophagectomy.

Authors:  Marc Vimolratana; Inderpal S Sarkaria; Debra A Goldman; Nabil P Rizk; Kay See Tan; Manjit S Bains; Prasad S Adusumilli; Smita Sihag; James M Isbell; James Huang; Bernard J Park; Daniela Molena; Valerie W Rusch; David R Jones; Matthew J Bott
Journal:  Ann Thorac Surg       Date:  2020-11-04       Impact factor: 5.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.